New Key Statistics Module, Z-Score and F-Score
NAS:VRNA Key Ratios
| Market Cap $ M | 3,685.68 |
| Enterprise Value $ M | 3,471.95 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 714.14 |
| Price/Book | 28.15 |
| Price/Sales | 652.77 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 5.00 |
| EPS (TTM) $ | -2.00 |
| Beneish M-Score | 4.95 |
| 10-y EBITDA Growth Rate % | -15.40 |
| 5-y EBITDA Growth Rate % | 25.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -25.32 |
| EV-to-EBITDA | -25.50 |
| PEG | -- |
| Shares Outstanding M | 81.83 |
| Net Margin (%) | -2,733.34 |
| Operating Margin % | -2,690.33 |
| Pre-tax Margin (%) | -2,698.40 |
| Quick Ratio | 12.88 |
| Current Ratio | 13.03 |
| ROA % (ttm) | -45.04 |
| ROE % (ttm) | -74.15 |
| ROIC % (ttm) | -550.21 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.79 |
VRNA Number of Guru Trades
VRNA Volume of Guru Trades
Gurus Latest Trades with NAS:VRNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Verona Pharma PLC Insider Transactions
No Available Data
News about NAS:VRNA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers